 And doctors were required to provide ongoing in-person care, the day one in-person administration of the first drug, day three in-person administration of the second drug, and day 14 visit to check for complications. The FDA included a black box warning to alert women that surgical intervention may be necessary and inform them of what to do in the event of an emergency, noting that access to emergency care was critical.